½ÃÀ庸°í¼­
»óǰÄÚµå
1792668

¾à±¹ ÀÚµ¿È­ ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø, Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)

Pharmacy Automation Market Size, Share, Trends and Forecast by Product Type, Application, End-User, and Region, 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 148 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¾à±¹ ÀÚµ¿È­ ½ÃÀå ±Ô¸ð´Â 2024³â 67¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â¿¡´Â 120¾ï ´Þ·¯¿¡ À̸£°í, 2025³âºÎÅÍ 2033³â±îÁö 6.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇöÀç ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç 2024³â ½ÃÀå Á¡À¯À²Àº 54.4%¸¦ ³Ñ¾ú½À´Ï´Ù. ÀÇ·á °úÁ¤¿¡¼­ ¿À·ù¸¦ ÁÙÀÏ Çʿ伺 Áõ°¡, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ·Îº¿ °øÇÐ, ÀΰøÁö´É, ¸Ó½Å·¯´× ¹× µ¥ÀÌÅÍ ºÐ¼®ÀÇ ´Ù¾çÇÑ Áøº¸°¡ ½ÃÀåÀ» ÃßÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù.

´Ù¾çÇÑ ¸¸¼º ÁúȯÀÇ ¹ß»ýÀÌ ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀǾàǰ ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ±× °á°ú, ¾à±¹ÀÇ ¼ö°¡ ´õ¿í Áõ°¡Çϰí, ¾à±¹ ÀÚµ¿È­ ¼­ºñ½ºÀÇ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á ºÐ¾ß°¡ °è¼Ó ÁøÈ­Çϸ鼭 ¾à±¹ ÀÚµ¿È­´Â ±âÁ¸ÀÇ ¼öÀÛ¾÷ °úÁ¤¿¡¼­ ºñÈ¿À²¼ºÀ» ÇØ°áÇϰí Á¤È®¼ºÀ» ³ôÀ̰í ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â Áß¿äÇÑ µµ±¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ´Ù¸¥ ÁÖ¿ä µ¿ÇâÀº ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)À» ¾à±¹ ÀÚµ¿È­ ½Ã½ºÅÛ¿¡ ÅëÇÕÇÏ´Â °ÍÀÔ´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ ¼Ö·ç¼ÇÀº ¾à¹° ¼ö¿ä ¿¹Ãø, Àç°í ¼öÁØ ÃÖÀûÈ­, ³¶ºñ °¨¼Ò µîÀÇ ´É·ÂÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ±â¼úÀº º¸´Ù Á¤È®ÇÑ º¹¿ë·® °è»êÀ» °¡´ÉÇÏ°Ô Çϰí ó¹æÀü¿¡ ÀáÀçÀûÀÎ ÇØ·Î¿î ½Ç¼ö°¡ ¾øÀ½À» º¸ÀåÇÔÀ¸·Î½á ȯÀÚÀÇ ¾ÈÀü¿¡ ±â¿©ÇÕ´Ï´Ù. ¶ÇÇÑ, ¿¹Ãø ºÐ¼®À» »ç¿ëÇÔÀ¸·Î½á ¾à±¹Àº ȯÀÚÀÇ ¿ä±¸¸¦ ¿¹ÃøÇϰí, Åõ¾à ÀÌÇà °úÁ¤À» °£¼ÒÈ­ÇÒ ¼ö ÀÖ¾î Àü¹ÝÀûÀÎ ¼­ºñ½º Á¦°øÀÌ °³¼±µË´Ï´Ù.

¹Ì±¹Àº ÀÇ·á±â¼úÀÇ Áøº¸°¡ ÇöÀúÇϱ⠶§¹®¿¡ ¾à±¹ ÀÚµ¿È­ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÇ ÀÇ·á»ê¾÷Àº ³ëµ¿·Â ºÎÁ·, ºñ¿ë »ó½Â, ÀǾàǰ ¼ö¿ä Áõ°¡ µîÀÇ °úÁ¦¸¦ ÇØ°áÇϱâ À§ÇØ ÁøÈ­Çϰí ÀÖÀ¸¸ç, ÀÚµ¿È­ ±â¼úÀº ¾à±¹ ¾÷¹«ÀÇ ±Ù´ëÈ­¿¡ ÇʼöÀûÀÎ µµ±¸·Î ´ëµÎÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎÀº Àα¸Åë°èÀû ¿äÀÎ, ±â¼ú Çõ½Å, Á¤Ã¥Àü°³¿¡ ÀÇÇØ Çü¼ºµÈ ÀÇ·á½Ã½ºÅÛÀÇ ±¤¹üÀ§ÇÑ º¯È­¸¦ ¹Ý¿µÇÕ´Ï´Ù. AI¿Í ML ±â¼úÀº ¹Ì±¹ÀÇ ¾à±¹ ÀÚµ¿È­ ½Ã½ºÅÛ¿¡ Á¡Á¡ ÅëÇÕµÇ¾î ±× ´É·ÂÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. AI¸¦ žÀçÇÑ ÅøÀ» ÅëÇØ ¾à±¹Àº Àç°í °ü¸® ÃÖÀûÈ­, Åõ¾à ¼ö¿ä ¿¹Ãø, ȯÀÚ °ü¸® °³º°È­¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ML ¾Ë°í¸®ÁòÀº °ú°Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ¹Ì·¡ µ¿ÇâÀ» ¿¹ÃøÇÏ°í ¾à±¹ÀÌ Ç°Àý ¹× °úÀ× Àç°í¸¦ ¹æÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ AI´Â ÀáÀçÀûÀÎ ¾à¹° »óÈ£ÀÛ¿ë°ú ó¹æÀü ¿À·ù¸¦ È®ÀÎÇϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç ȯÀÚÀÇ ¾ÈÀü¼º Çâ»ó¿¡ ±â¿©ÇÕ´Ï´Ù. IMARC ±×·ìÀº ¹Ì±¹ÀÇ ML ½ÃÀåÀº 2033³â±îÁö 989¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

¾à±¹ ÀÚµ¿È­ ½ÃÀå µ¿Çâ :

ÀÇ·á ÇÁ·Î¼¼½ºÀÇ ¿À·ù °¨¼Ò ¿ä±¸ Áõ°¡

Åõ¾à ½Ç¼ö´Â ȯÀÚÀÇ ¾ÈÀü°ú Çູ¿¡ ½É°¢ÇÑ °á°ú¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÇ·á Á¦»ê¾÷ü¿Í ¾à±¹¿¡¼­´Â ¿À·ù À§ÇèÀ» ÁÙÀ̰í ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ¾à±¹ ÀÚµ¿È­ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÚµ¿ Á¦Á¦ ½Ã½ºÅÛ ¹× ¹ÙÄÚµå ½ºÄ³´× ±â¼ú°ú °°Àº ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº Åõ¾à ½Ç¼ö¸¦ ÁÙÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº Á¤È®ÇÑ Á¦Á¦, ó¹æÀü È®ÀÎ, Åõ¾à ÁÖ¹®°ú ȯÀÚ ÇÁ·ÎÆÄÀÏÀÇ Á¶ÇÕÀ» Áö¿øÇÏ¿© ÀÎÀû ½Ç¼öÀÇ °¡´É¼ºÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. Institute of Medicine(¹Ì±¹ÀÇÇבּ¸¼Ò)ÀÇ ÃßÁ¤¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â ¿¬°£ Àû¾îµµ 150¸¸¸íÀÌ Åõ¾à ½Ç¼öÀÇ ÇÇÇØ¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ÀÚµ¿ Á¶Á¦ ¹× ¹ÙÄÚµå ½ºÄµ°ú °°Àº ¾à±¹ ÀÚµ¿È­ ½Ã½ºÅÛÀº Åõ¾à ½Ç¼ö¸¦ ÃÖ´ë 50%±îÁö ÁÙÀÌ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÇÕµ¿À§¿øÈ¸(Joint Commission)¿Í ½ÄǰÀǾ౹(FDA) µîÀÇ ±ÔÁ¦±â°üµµ Åõ¾àÀÇ ¾ÈÀü¼ºÀ» Áß½ÃÇϰí ÀÇ·á Á¦»ê¾÷ü¿¡°Ô ½Ç¼ö¸¦ ÁÙÀ̱â À§ÇÑ ´ëÃ¥ÀÇ ½Ç½Ã¸¦ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ÀÇ µÞ¹ÞħÀº ÄÄÇöóÀ̾𽺠±âÁØÀ» ÃæÁ·Çϱâ À§ÇÑ ¾à±¹ ÀÚµ¿È­ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

·Îº¿ °øÇÐ, ÀΰøÁö´É, µ¥ÀÌÅÍ ºÐ¼®¿¡¼­ ´Ù¾çÇÑ ±â¼úÀÇ ¹ßÀü

·Îº¿ Á¦Á¦ ½Ã½ºÅÛÀº ¾à¹°ÀÇ Á¤È®ÇÑ Ä«¿îÆ® ¹× Æ÷ÀåÀ» ¼öÇàÇÏ°í ¿À·ù¸¦ ÁÙÀ̰í È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ·Îº¿Àº ´ë·®ÀÇ Ã³¹æÀü¿¡ ´ëÀÀÇÏ¿© º¸´Ù ºü¸£°í Á¤È®ÇÑ Á¶Á¦¸¦ ½ÇÇöÇÕ´Ï´Ù. AI ¹× ML ¾Ë°í¸®Áò°ú ÅëÇÕµÈ ·Îº¿ ½Ã½ºÅÛÀº µ¥ÀÌÅÍ ÆÐÅÏ¿¡¼­ ÇнÀÇÏ¿© Á¦Á¦ ÇÁ·Î¼¼½º¸¦ ÃÖÀûÈ­ÇÏ°í º¯È­ÇÏ´Â ¾à±¹ÀÇ ¿ä±¸¿¡ ÀûÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ AI¿Í ML ¾Ë°í¸®ÁòÀº ¾à±¹ ÀÚµ¿È­ÀÇ ´Ù¾çÇÑ Ãø¸éÀ» °³¼±ÇÏ´Â µ¥ Ȱ¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ȯÀÚ µ¥ÀÌÅÍ, ¾à·Â, ¾à¹° »óÈ£ ÀÛ¿ëÀ» ºÐ¼®Çϰí ÀÓ»ó ÀÇ»ç °áÁ¤ Áö¿øÀ» Á¦°øÇÏ°í ¾à»ç°¡ ÃæºÐÇÑ Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ¶ÇÇÑ µ¥ÀÌÅÍ ºÐ¼® µµ±¸´Â ¾à¹° »ç¿ë ÆÐÅÏÀ» ºÐ¼®Çϰí, µ¿ÇâÀ» ÆÄ¾ÇÇϰí, Àç°í ¼öÁØÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÑ º¸°í¼­¿¡ µû¸£¸é µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ Àç°í¸¦ ÃÖÀûÈ­ÇÏ°í ¾à¹° ³¶ºñ¸¦ 10-20% ÁÙÀÌ°í ¾÷¹« È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖÀ¸¹Ç·Î ½ÃÀå ¼ºÀåÀÌ ÃËÁøµË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀº ¾à±¹ÀÌ Àç°í ¼öÁØ Á¶Á¤, Á¶Á¦ ÆÐÅÏ ½Äº°, ¾÷¹« È¿À²¼º °³¼± µî µ¥ÀÌÅÍ ÁÖµµ ÀÇ»ç °áÁ¤À» ³»¸®°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù.

¸¸¼º Áúȯ Áõ°¡

¸¸¼º ÁúȯÀº Á¾Á¾ Àå±âÀûÀÎ Åõ¾à °ü¸®°¡ ÇÊ¿äÇϸç 󹿷®ÀÌ Å©°Ô Áõ°¡ÇÕ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ¸¸¼ºÁúȯÀº Àü ¼¼°è »ç¸Á¿øÀÎÀÇ 71%¸¦ Â÷ÁöÇϸç 󹿷® Áõ°¡¸¦ ÃËÁøÇϰí ÀÖ´Ù°í ÇÕ´Ï´Ù. ¾à±¹ ÀÚµ¿È­ ·Îº¿ Á¦Á¦ ½Ã½ºÅÛ ¹× ó¹æÀü ÃæÀü ÀÚµ¿È­¿Í °°Àº ½Ã½ºÅÛÀ» ÅëÇØ ¾à±¹Àº ´ë·®ÀÇ Ã³¹æÀüÀ» È¿À²ÀûÀ¸·Î ó¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÚµ¿È­µÈ ½Ã½ºÅÛÀº Á¤È®ÇÏ°í ½Ã±â ÀûÀýÇÑ Á¦ÇüÀ» º¸ÀåÇϰí ȯÀÚÀÇ ´ë±â ½Ã°£À» ´ÜÃàÇÏ¸ç ¾à±¹ÀÇ Àü¹ÝÀûÀÎ ¿öÅ©Ç÷ο츦 °³¼±ÇÕ´Ï´Ù. ¶ÇÇÑ, ¾à±¹ ÀÚµ¿È­´Â ÀÚµ¿ ó¹æÀü º¸Ãæ ½Ã½ºÅÛ ¹× ¾à¹° Æ÷Àå ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á º¹¾à Áؼö¸¦ ÃËÁøÇϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚ´Â Æí¸®ÇÏ°Ô ¾à¹°À» ¹ÞÀ» ¼ö ÀÖ°í ÃæºÐÇÑ ¾çÀ» È®º¸ÇÏ°í ¸¶½Ã´Â °ÍÀ» ÀØÀ» °¡´É¼ºÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¹Ç·Î ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ºÐ¼® ¹üÀ§¡¤¼ö¹ý

  • ºÐ¼® ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • ºÐ¼® ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ¾à±¹ ÀÚµ¿È­ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ±¸ºÐ : Á¦Ç° À¯Çüº°

  • ÀǾàǰ ÀÚµ¿ Á¶Á¦ ½Ã½ºÅÛ
  • ÀÚµ¿ ÀúÀå ¹× °Ë»ö ½Ã½ºÅÛ(AS/RS)
  • ÀÚµ¿ Æ÷Àå ¹× ¶óº§¸µ ½Ã½ºÅÛ
  • Ź»ó¿ë ÅÂºí¸´ Ä«¿îÅÍ
  • ±âŸ

Á¦7Àå ½ÃÀå ±¸ºÐ : ¿ëµµº°

  • ¾à Á¶Á¦ ¹× Æ÷Àå
  • ¾à º¸°ü
  • Àç°í °ü¸®

Á¦8Àå ½ÃÀå ±¸ºÐ : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ±âŸ

Á¦9Àå ½ÃÀå ±¸ºÐ : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • Ä¥·¹
    • Æä·ç
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Æ¢¸£Å°¿¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • À̶õ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ

Á¦10Àå SWOT ºÐ¼®

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Capsa Healthcare
    • Cerner Corp.
    • Kirby Lester LLC
    • KUKA AG
    • McKesson Corporation
    • Omnicell Technologies
    • RxSafe LLC
    • Scriptpro LLC
    • Swisslog Holding AG
    • Takazono Corp.
    • Talyst LLC
    • TCGRx Pharmacy Workflow Solutions
    • Yuyama Co. Ltd.
KTH 25.08.27

The global pharmacy automation market size was valued at USD 6.7 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 12.0 Billion by 2033, exhibiting a CAGR of 6.6% from 2025-2033. North America currently dominates the market, holding a market share of over 54.4% in 2024. The increasing need to reduce errors in medical processes, the growing prevalence of chronic diseases, and various advances in robotics, artificial intelligence, machine learning, and data analytics are some of the major factors propelling the market.

The occurrence of various chronic diseases is rising worldwide, which is also driving the demand for medicines. This, in turn, is further increasing the number of pharmacies, thereby catalyzing the need for pharmacy automation services. As the healthcare sector continues to evolve, pharmacy automation has emerged as a critical tool for addressing inefficiencies in traditional manual processes, enhancing accuracy, and improving patient outcomes. One of the other major trends includes the integration of Artificial Intelligence (AI) and Machine Learning (ML) in pharmacy automation systems. AI-powered solutions are enhancing the ability to predict medication demand, optimize inventory levels, and reduce waste. These technologies also contribute to patient safety by enabling more precise dose calculation and ensuring that prescriptions are free from potentially harmful errors. Additionally, the use of predictive analytics allows pharmacies to anticipate patient needs and streamline the medication fulfilment process, improving overall service delivery.

The United States has emerged as a major region in the pharmacy automation market because of the heightened advancements in healthcare technology. As the healthcare industry in the US evolves to address the challenges posed by workforce shortages, rising costs, and the increasing demand for medications, automation technologies have emerged as essential tools for modernizing pharmacy operations. Trends and drivers in the market reflect broader changes in the healthcare system, shaped by demographic factors, innovation, and policy developments. AI and ML technologies are increasingly being integrated into US pharmacy automation systems, further enhancing their capabilities. AI-powered tools enable pharmacies to optimize inventory management, predict medication demand, and personalize patient care. ML algorithms can analyze historical data to forecast future trends, helping pharmacies prevent stockouts or overstocking. Furthermore, AI plays a critical role in identifying potential medication interactions or errors in prescriptions, contributing to improved patient safety. The IMARC Group predicts that the US ML market is expected to reach USD 98.9 billion by 2033.

Pharmacy Automation Market Trends:

Increasing Need to Reduce Errors in Medical Processes

Medication errors can have severe consequences on patient safety and well-being. As a result, healthcare providers and pharmacies are increasingly adopting pharmacy automation solutions to reduce risk of errors as well as enhance patient outcomes. These systems, such as automated dispensing systems and barcode scanning technology, play a crucial role in reducing medication errors. They help ensure accurate medication dispensing, verify prescriptions, and cross-reference medication orders with patient profiles, minimizing the potential for human errors. The Institute of Medicine estimates that annually, medication errors harm at least 1.5 million people in the United States. Pharmacy automation systems, such as automated dispensing and barcode scanning, can help cut down medication errors by up to 50%. Moreover, regulatory bodies, such as the Joint Commission and the Food and Drug Administration (FDA), also place importance on medication safety and require healthcare providers to implement measures to reduce errors. This regulatory push further accelerates the adoption of pharmacy automation solutions to meet compliance standards.

Various Technological Advancements in Robotics, Artificial Intelligence and Data Analytics

Robotic dispensing systems can accurately count and package medications, reducing errors and enhancing efficiency. These robots can handle a high volume of prescriptions, ensuring faster and more precise medication dispensing. Robotic systems integrated with AI and ML algorithms can even learn from data patterns to optimize medication dispensing processes and adapt to changing pharmacy needs. Moreover, AI and ML algorithms are being utilized to improve various aspects of pharmacy automation. These technologies can analyze patient data, medication histories, and drug interactions to provide clinical decision support, helping pharmacists make informed decisions. Besides, data analytics tools can analyze medication usage patterns, identify trends, and optimize inventory levels. According to a report, data analytics can optimize inventory, leading to a 10-20% reduction in medication waste and improving operational efficiency, propelling market growth. These insights help pharmacies make data-driven decisions, such as adjusting stock levels, identifying medication dispensing patterns, and improving operational efficiency, thus propelling the market growth.

Growing Prevalence of Chronic Diseases

Chronic diseases often require long-term medication management, leading to a significant increase in prescription volumes. As per the World Health Organization (WHO), chronic diseases lead to 71% of deaths worldwide, driving higher prescription volumes. Pharmacy automation systems, such as robotic dispensing systems and prescription filling automation, enable pharmacies to handle larger prescription volumes efficiently. Automated systems ensure accurate and timely medication dispensing, reducing waiting times for patients and improving overall workflow in pharmacies. Moreover, pharmacy automation plays a crucial role in promoting medication adherence by providing automated prescription refill systems and medication packaging solutions. These systems help patients conveniently receive their medications, ensuring they have a sufficient supply and reducing the likelihood of missed doses, thus contributing to market growth.

Pharmacy Automation Industry Segmentation:

Analysis by Product Type:

  • Automated Medication Dispensing Systems
  • Automated Storage & Retrieval Systems
  • Automated Packaging & Labeling Systems
  • Tabletop Tablet Counters
  • Others

Automated medication dispensing systems leads the market with 24.8% of market share in 2024. Automated medication dispensing systems represent the largest segment due to various reasons. Automated medication dispensing systems ensure precise medication dosing and reduce the risk of human errors. These systems employ barcode scanning and verification, medication database integration, and robotic dispensing technology to accurately dispense medications. Moreover, these systems streamline the medication dispensing process, saving a lot of time and improving operational efficiency in pharmacies. They can handle a large volume of prescriptions quickly and accurately, reducing waiting times for patients and optimizing workflow for pharmacy staff. Besides, automated medication dispensing systems often include inventory management functionalities, enabling real-time tracking of medication stock levels, expiration dates, and batch numbers. This integration ensures efficient inventory control, reducing the risk of medication shortages or wastage.

Analysis by Application:

  • Drug Dispensing and Packaging
  • Drug Storage
  • Inventory Management

Drug dispensing and packaging are essential steps in the medication workflow process within pharmacies. Automation solutions that focus on drug dispensing and packaging address the need for accurate and efficient medication management. These systems streamline the process by automating tasks such as counting pills, verifying prescriptions, labeling medications, and packaging them for individual patients. The ability to automate these critical steps significantly improves workflow efficiency and reduces the potential for errors, leading to increased demand for these automation solutions. Besides, these automation systems often incorporate barcode scanning, medication verification, and advanced algorithms to ensure accurate medication dispensing and packaging, enhancing patient safety and reducing adverse drug events. Technological advancements, such as the integration of AI, ML, and IoT, are expected to further transform the drug dispensing and packaging segment. AI and ML can enhance predictive analytics for inventory management, while IoT-enabled devices can provide real-time monitoring of packaging and dispensing systems. These innovations are likely to drive greater efficiency and accuracy in the coming years.

Analysis by End-User:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Retail pharmacies stand as the largest component in 2024, holding 51.2% of the market. Retail pharmacies cater to a large volume of patients, serving as accessible points of care within communities. The high footfall and patient demand drive the need for efficient and streamlined pharmacy operations, making retail pharmacies a significant market segment for pharmacy automation solutions. Moreover, retail pharmacies often prioritize customer convenience and aim to differentiate themselves through superior service. Pharmacy automation solutions contribute to this goal by reducing waiting times, minimizing medication errors, and enhancing overall customer experience, thus accelerating the product adoption rate. Technology is playing a pivotal role in reshaping the operations and services of retail pharmacies. One of the most significant advancements is the adoption of pharmacy automation technologies, such as robotic prescription dispensing systems and automated inventory management tools. These technologies enhance efficiency, reduce human error, and allow pharmacists to spend more time on patient-facing services. Robotic systems can quickly and accurately fill prescriptions, enabling pharmacies to handle higher volumes with fewer errors, which is particularly important in high-traffic locations.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • Iran
    • United Arab Emirates
    • Others

In 2024, North America represented the highest market share at 54.4%. North America has been at the forefront of technological advancements, including pharmacy automation. The region has a robust healthcare infrastructure and a high level of adoption and investment in advanced technologies. This has led to the development and deployment of innovative pharmacy automation solutions, making North America a leading market for these technologies. Moreover, the region has stringent regulatory standards for medication safety and quality control. Regulatory bodies like the US Food and Drug Administration (FDA) prioritize patient safety and require compliance with specific guidelines for medication dispensing and management. Pharmacy automation solutions help pharmacies meet these standards and ensure accurate and safe medication dispensing, making them highly sought after in the region. In 2024, Swisslog Healthcare collaborated with BD for mechanizing pharmacy inventory management in hospitals across the United States.

Key Regional Takeaways:

United States Pharmacy Automation Market Analysis

In North America, the United States accounted for 84.50% of the total market share. The US market is driven by increasing healthcare demands and the need for operational efficiency in pharmacies. According to the National Community Pharmacists Association, in 2023, the United States had over 19,400 independent pharmacies, where automation plays a critical role in reducing errors and improving workflow. Adoption by hospitals of automated dispensing systems is growing, partly as a result of increased patient safety attention, and retail pharmacies embrace robotic systems for medication dispensing. Some of the prominent companies that lead in the incorporation of such technologies as AI-driven inventory management include BD (Becton Dickinson) and Omnicell. With an estimation from industry figures that automation reduces dispensing errors up to 85%, adoption is likely to rise further. Federal incentives for the digitization of healthcare innovation have fueled this growth. As a result, the growing incidence of chronic diseases ensures that automated solutions remain in steady demand within the U.S. pharmacy market.

Europe Pharmacy Automation Market Analysis

Increased healthcare cost and stringent regulations on the security of medications are forcing the European market. Automation, according to Eurostat, is highly driven by an aging population in Europe and continuously increasing cases of chronic diseases, which facilitate medication demand. Germany takes the lead with major investments in robotic dispensing systems for hospitals and retail chains, supported by policies such as the "Digital Health Act." France and the UK focus more on automation in reducing the cost of labor and efficiency gains. Companies such as Swisslog and KUKA keep innovating in dose accuracy and inventory control through AI. According to Pharmaceutical Journal, for instance, a Danish study observed a 57% decrease in medication errors following the implementation of an automated system. Moreover, partnerships between governments and private firms in countries like Italy and Spain are accelerating implementation, making Europe a leader in the adoption of pharmacy technology.

Asia Pacific Pharmacy Automation Market Analysis

The Asia Pacific market is expanding with rapid growth in the health infrastructure and increasing adoption of technology. As reported by the Ministry of Health and Family Welfare, India's health expenditure has been increased to USD 10.75 Billion in 2023 with automation playing an important role in enhancing the pharmacy services. China's focus on upgrading hospitals and smart healthcare also supports its objective of automating 50% of its pharmacies by 2025. Retail pharmacies in Japan are also using robotic dispensing systems to deal with workforce shortages. Companies like Yuyama and Parata Systems are taking advantage of this trend by providing scalable solutions to meet regional requirements. A report by Frost & Sullivan stated that pharmacy automation in the region saves up to 60% in terms of efficiency in dispensing, appealing to private and public healthcare facilities. The Asia Pacific is becoming an emerging hub for competition and investment in innovative pharmacy automation technologies.

Latin America Pharmacy Automation Market Analysis

The Latin American market for pharmacy automation is growing constantly, driven by increased accessibility to healthcare and digitization. According to the Pan American Health Organization, health expenditure in Brazil reached an estimated USD 161 Billion for 2023, with investment in the automation of in-patient pharmacies to improve medicine safety. Mexico is likewise investing in automated dispensing systems of public hospitals, which are being complemented by government funding. Retail pharmacies in the region, such as Farmacias Similares, embrace robotics to serve customers better. Industry reports say automation reduces operational costs by up to 30%. Such savings make it appealing for cost-sensitive markets to invest in automation. Companies such as BD and Omnicell continue their expansion in Latin America with the help of local distributors. Moreover, telepharmacy is integrating automation to support efficient remote medication management. The momentum in the market, therefore, remains strong.

Middle East and Africa Pharmacy Automation Market Analysis

Healthcare modernization and new investments in digital health promote the Middle East and Africa market. For instance, the International Trade Administration estimates that healthcare spending in Saudi Arabia 2023 is around USD 50.4 Billion with high investment in the hospital automation aspect, which includes pharmacy systems; the United Arab Emirates already implements robotic dispensing systems of pharmacies to avoid errors on the patients. Private hospitals in Africa are witnessing an increased adoption of automated systems. Leaders such as Capsa Healthcare are collaborating with regional players to enhance their presence. WHO estimates that medication errors are one of the reasons for 8% hospital readmissions, thus driving demand for error-reducing technologies. Government-backed initiatives in Qatar and Egypt are further fostering pharmacy automation adoption, making the region a growing market for advanced pharmacy technologies.

Competitive Landscape:

The competitive landscape of the market is characterized by the presence of several key players competing for market share. These companies offer a range of pharmacy automation solutions and constantly innovate to stay ahead in the market. At present, key players are developing advanced pharmacy automation solutions that address the evolving needs of healthcare providers and pharmacies. This includes improving accuracy, expanding functionalities, integrating AI and ML capabilities, and enhancing user experience. For instance, in 2024, Omnicell announced the launch of Central Med Automation Service, which is a subscription-based solution created to assist health systems establish and optimize centralized medication management for consolidated pharmacy services centers (CPSCs). They are also collaborating with healthcare systems, retail pharmacy chains, and other industry stakeholders to integrate their automation solutions with existing healthcare infrastructure. Moreover, key players are expanding their presence in different geographic regions by targeting untapped markets.

The report provides a comprehensive analysis of the competitive landscape in the pharmacy automation market with detailed profiles of all major companies, including:

  • Baxter International Inc.
  • Becton Dickinson and Company
  • Capsa Healthcare
  • Cerner Corp.
  • Kirby Lester LLC
  • KUKA AG
  • McKesson Corporation
  • Omnicell Technologies
  • RxSafe LLC
  • Scriptpro LLC
  • Swisslog Holding AG
  • Takazono Corp.
  • Talyst LLC
  • TCGRx Pharmacy Workflow Solutions
  • Yuyama Co. Ltd.

Key Questions Answered in This Report

  • 1.What is pharmacy automation?
  • 2.How big is the pharmacy automation market?
  • 3.What is the expected growth rate of the global pharmacy automation market during 2025-2033?
  • 4.What are the key factors driving the global pharmacy automation market?
  • 5.What is the leading segment of the global pharmacy automation market based on product type?
  • 6.What is the leading segment of the global pharmacy automation market based on application?
  • 7.What is the leading segment of the global pharmacy automation market based on end-user?
  • 8.What are the key regions in the global pharmacy automation market?
  • 9.Who are the key players/companies in the global pharmacy automation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmacy Automation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Automated Medication Dispensing Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Automated Storage & Retrieval Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Automated Packaging & Labeling Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Tabletop Tablet Counters
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Dispensing and Packaging
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Storage
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inventory Management
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Japan
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 India
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 South Korea
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Australia
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Argentina
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
    • 9.4.4 Colombia
      • 9.4.4.1 Market Trends
      • 9.4.4.2 Market Forecast
    • 9.4.5 Chile
      • 9.4.5.1 Market Trends
      • 9.4.5.2 Market Forecast
    • 9.4.6 Peru
      • 9.4.6.1 Market Trends
      • 9.4.6.2 Market Forecast
    • 9.4.7 Others
      • 9.4.7.1 Market Trends
      • 9.4.7.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Turkey
      • 9.5.1.1 Market Trends
      • 9.5.1.2 Market Forecast
    • 9.5.2 Saudi Arabia
      • 9.5.2.1 Market Trends
      • 9.5.2.2 Market Forecast
    • 9.5.3 Iran
      • 9.5.3.1 Market Trends
      • 9.5.3.2 Market Forecast
    • 9.5.4 United Arab Emirates
      • 9.5.4.1 Market Trends
      • 9.5.4.2 Market Forecast
    • 9.5.5 Others
      • 9.5.5.1 Market Trends
      • 9.5.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Baxter International Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Capsa Healthcare
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cerner Corp.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Kirby Lester LLC
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 KUKA AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 McKesson Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Omnicell Technologies
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 RxSafe LLC
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Scriptpro LLC
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Swisslog Holding AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Takazono Corp.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
    • 13.3.13 Talyst LLC
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
    • 13.3.14 TCGRx Pharmacy Workflow Solutions
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio
    • 13.3.15 Yuyama Co. Ltd.
      • 13.3.15.1 Company Overview
      • 13.3.15.2 Product Portfolio
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦